Leah E. Cowen
Leah E. Cowen | |
|---|---|
| Academic background | |
| Education | BSc, University of British Columbia PhD, 2002, University of Toronto |
| Thesis | Population genomics of drug resistance in the pathogenic yeast Candida albicans. (2002) |
| Academic work | |
| Institutions | University of Toronto |
Leah Elizabeth Cowen is a Canadian mycologist and the Vice-President, Research and Innovation, and Strategic Initiatives at the University of Toronto.
Early life and education
[edit]Cowen earned her Bachelor of Science degree from the University of British Columbia and her PhD from the University of Toronto (U of T).[1] During this time, she received a postgraduate scholarship from the Natural Sciences and Engineering Research Council and completed her postdoctoral fellowship at the Whitehead Institute. While at MIT, she also received the 2005 Genzyme Postdoctoral Fellowship.[2]
Career
[edit]Cowen returned to her alma mater, U of T, in 2007 as an assistant professor in the department of molecular genetics.[3] While serving in this role, her laboratory showed that growth of the Candida albicans fungus was tied to the function of heat-shock protein 90 (Hsp90).[4] In 2012, Cowen was appointed a Canada Research Chair (CRC) in Microbial Genomics and Infectious Disease.[5] As a CRC, Cowen began using specialized genomics technology to examine how fungal pathogens become resistant to drugs and cause human disease.[6] She also became the co-director of the Canadian Institute for Advanced Research program "Fungal Kingdom: Threats & Opportunities" and was the co-founder and chief scientific officer of biotechnology firm Bright Angel Therapeutics.[3] As such, Cowen received a 2015 Natural Sciences and Engineering Research Council E.W.R. Steacie Memorial Fellowships.[6][7]
In 2018, Cowen was re-appointed a Tier 1 Canada Research Chair in Microbial Genomics & Infectious Disease.[8] In November 2020, Cowen was appointed the University of Toronto’s first associate vice-president of research.[3] She was also elected a fellow of the American Association for the Advancement of Science in the same month.[9] The following year, Cowen was named one of four new editors for the blog Genes to Genomes run through the Genetics Society of America.[10]
References
[edit]- ^ "Leah E. Cowen". Canadian Institute for Advanced Research. Retrieved November 6, 2021.
- ^ Cameron, David (September 21, 2005). "Leah Cowen awarded Genzyme Fellowship". Whitehead Institute. Retrieved November 6, 2021.
- ^ a b c Kalvapalle, Rahul (November 20, 2020). "Leah Cowen appointed U of T's first associate vice-president, research". University of Toronto. Retrieved November 6, 2021.
- ^ "Researchers uncover molecular pathway through which common yeast becomes fungal pathogen". Eurekalert. March 16, 2012. Retrieved November 6, 2021.
- ^ Hall, Jenny (March 13, 2012). "U of T wins four new Canada Research Chairs". University of Toronto. Retrieved November 6, 2021.
- ^ a b "2015 NSERC E.W.R. Steacie Memorial Fellowships". Natural Sciences and Engineering Research Council. Retrieved November 6, 2021.
- ^ Hall, Jenny (February 17, 2015). "NSERC awards: big night for U of T as researchers take home three Steacie Fellowships, one postdoctoral prize". University of Toronto. Retrieved November 6, 2021.
- ^ Sorensen, Chris (May 3, 2018). "Thinking different: U of T's newest Canada Research Chairs are exploring new frontiers in knowledge and innovation". University of Toronto. Retrieved November 6, 2021.
- ^ "Leah Cowen elected fellow of the American Association for the Advancement of Science". University of Toronto. November 24, 2020. Retrieved November 6, 2021.
- ^ "Welcome to new editors at G3 and GENETICS". Genes to Genomes. May 31, 2021. Retrieved November 6, 2021.
External links
[edit]- Leah E. Cowen publications indexed by Google Scholar
| Authority control databases: Academics |
|---|
